Skip to content
DataLookout
Menu

ALTNCT04753190

Light Timing Study

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 17, 2026
    • Enrollment target: 84 to 81
    • Study completion date: May 18, 2025 to May 31, 2026
  2. Notable Eligibility criteria expanded, about 2 words
  3. Minor Trial status: Recruiting to Completed
    • Enrollment target: estimated 113 to confirmed 84
    • Primary and study completion dates changed from estimate of Jun 30, 2026 to May 18, 2025
    • Site details revised
    v8
  4. Minor Primary and study completion dates: Jun 2026 to Jun 30, 2026v7
  5. Minor Site contact updatedv6
Show 3 earlier versionsHide 3 earlier versions
  1. Minor Start date changed from estimate of Aug 2022 to Aug 22, 2022v4
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Primary and study completion dates: Aug 31, 2025 to Jun 2026
    • Start date: Jun 4, 2022 to Aug 2022
    • Eligibility criteria revised
    • Study description shortened, about 9 words
    • Site details revised
    • Study title shortened, about 1 word
  3. Notable Eligibility criteria revisedv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary and study completion dates: Sep 2025 to Aug 31, 2025
    • Start date: Jun 2022 to Jun 4, 2022
    • Study description shortened, about 73 words
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Dim Light Melatonin Onset (DLMO) Phase Shift Change
Timeframe: Change in DLMO phase from baseline (day 8) to final phase assessment (day 13)

Arms and interventions

Dim Room Light ControlPlacebo comparator

Participants in the dim room light control group will not receive any bright light exposure.

Morning Bright Light Only (MBL)Experimental

Participants in the morning bright light (MBL) group will receive a 3-h bright light exposure from 2 light boxes on 3 consecutive mornings in the laboratory. Bright light will be timed for each individual based on their baseline sleep schedule to shift the circadian timing system earlier ("phase advance").

Afternoon Light Only (ABL)Experimental

Participants in the afternoon bright light (ABL) group will receive a 3-h bright light exposure from 2 light boxes on 3 consecutive afternoons in the laboratory. Bright light will be timed for each individual based on their baseline sleep schedule to shift the circadian timing system earlier ("phase advance").

Morning + Afternoon Light (MBL+ ABL)Experimental

Participants in the morning bright light + afternoon bright light (MBL+ ABL) group will receive bright light from 2 light boxes on 3 consecutive days in the laboratory. The morning exposure will be 1.5 h and the afternoon exposure will be 1.5 h. Bright light exposures will be timed for each individual based on their baseline sleep schedule to shift the circadian timing system earlier ("phase advance").

Behavioral: Baseline Sleep Satiation and Phase Stabilization, Gradually Shifted Sleep

Sites

1 site in 1 country

  • Rush University Medical CenterChicago, Illinois, United States